Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mydecine Innovations Group Inc
(OP:
MYCOF
)
0.0068
UNCHANGED
Streaming Delayed Price
Updated: 3:24 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mydecine Innovations Group Inc
< Previous
1
2
3
Next >
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
June 30, 2021
Institutional analysts are taking a liking to the industry ...
Via
Benzinga
Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform
June 21, 2021
Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Mydecine Identifies 4 Psychedelic-Related Drugs to Tackle the Mental Health Crisis
June 17, 2021
Photo by Christopher Ott on
Via
Benzinga
Mydecine Innovations Group Launches AI-Assisted Drug Discovery Program
June 16, 2021
Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF), a biotech company in the ...
Via
Benzinga
Psychedelic Drug Stocks Index -21% In May; Now -25% YTD
May 31, 2021
46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index.
Via
Talk Markets
How This Psychedelic Company Could Lead A Turnaround For The Sector
April 10, 2021
Compass Pathways PLC (NASDAQ:CMPS) is often viewed as the leader in the psychedeli...
Via
Benzinga
Mydecine Unveils Four Psychedelic Drug Candidates
April 07, 2021
Mydecine Innovations Group (OTC:MYCOF), a Denver-based psychedelics research company...
Via
Benzinga
Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility
May 28, 2021
The Nasdaq welcomed its third psychedelics company this week, with
Via
Benzinga
Mydecine To Spin-Out Its U.S. Cannabis Assets By Mid July
May 19, 2021
Psychedelics and mycology company, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Next Psychedelic Stock To Uplist On The Nasdaq?
May 04, 2021
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next?
Via
Talk Markets
Mydecine Posts $26.9M Net Loss For 2020: What's Ahead For Psychedelic Stock
May 04, 2021
Denver-based Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF
Via
Benzinga
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
April 27, 2021
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive.
Via
Talk Markets
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021
April 20, 2021
Welcome to the Cannabis...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
April 13, 2021
Welcome to the Cannabis...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee
April 12, 2021
Entheon Biomedical Corp. announced the
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.